Fernando de Mora

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2021
Publications (10 Years): 3

Top Topics

End Stage Renal Disease

Allergic Rhinitis

Health Insurance

Ejection Fraction

Top Venues

British journal of clinical pharmacology

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Universitat Autonoma de Barcelona Facultat de Medicina

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitat Autonoma de Barcelona Facultat de Medicina Mar 01 1988

Spain

Doctor :: Farmacologia, Terapèutica i Toxicologia

Publications

Adrián Urbano, Judith Plaza, Sandra Turon, Anna Pujol, Cristina Costa-Farré, Alberto Marco, Cesar Picado, Rosa Torres, Fernando de Mora
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma. Allergy 76 (10) (2021)
Fernando de Mora, Alejandro Balsa, María Cornide-Santos, Y José Manuel Carrascosa, Sara Marsal, Francisco Javier García-Alonso, Miguel-Angel Abad, Rafael F Duarte, Michael Wiechmann, Rafael Martínez
Biosimilar and interchangeable: Inseparable scientific concepts? British journal of clinical pharmacology 85 (11) (2019)
Fernando de Mora
Biosimilars: A Value Proposition. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 33 (4) (2019)
Fernando de Mora
Biosimilar: what it is not. British journal of clinical pharmacology 80 (5) (2015)